RGC32 抗体 (AA 98-137) (Cy7)
Quick Overview for RGC32 抗体 (AA 98-137) (Cy7) (ABIN1418588)
抗原
See all RGC32 (C13orf15) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 98-137
-
交叉反应
- 人, 小鼠, 大鼠
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human RGC32
-
亚型
- IgG
-
-
-
-
应用备注
- IF(IHC-P) 1:50-200
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- RGC32 (C13orf15) (Chromosome 13 Open Reading Frame 15 (C13orf15))
-
别名
- RGC32
-
背景
-
Synonyms: RGC32, RGC-32, C13orf15, bA157L14.2, Regulator of cell cycle RGCC, Response gene to complement 32 protein, RGCC
Background: Modulates the activity of cell cycle-specific kinases. Enhances CDK1 activity. May contribute to the regulation of the cell cycle. May inhibit growth of glioma cells by promoting arrest of mitotic progression at the G2/M transition. Fibrogenic factor contributing to the pathogenesis of renal fibrosis through fibroblast activation.
-
基因ID
- 28984
-
UniProt
- Q9H4X1
抗原
-